|
Quotes & Info
|
| AFFY > SEC Filings for AFFY > Form 8-K on 25-Feb-2013 | All Recent SEC Filings |
25-Feb-2013
Other Events, Financial Statements and Exhibits
On February 23, 2013, Affymax, Inc. (the "Company") and Takeda Pharmaceutical Company Limited ("Takeda") announced a nationwide voluntary recall of OMONTYS® (peginesatide) Injection as a result of new postmarketing reports regarding serious hypersensitivity reactions, including anaphylaxis which can be life-threatening or fatal.
A press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits:
Exhibit No. Description
99.1 Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots
of OMONTYS ® (peginesatide) Injection
|
|
|